Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database
Epilepsy & Behavior · 2024
DOI: 10.1016/j.yebeh.2024.109784 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Hyun Kyung Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Anticonvulsants, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Pharmacovigilance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to compare and characterize the safety profiles of new antiseizure medications (ASMs) using a nationwide pharmacovigilance database from a long-term perspective in Korea. METHODS: We reviewed adverse event reports from the Korea Adverse Event Reporting System database between January 2013 and December 2022 for descriptive analysis of six new ASMs (lacosamide, levetiracetam, lamotrigine, oxcarbazepine, topiramate, and zonisamide). We investigated the frequency and characteristics of adverse drug reactions (ADRs) based on the MedDRA terminology, system organ classes, and modified WHO classification. RESULTS: We identified 5,733 reported cases of ADRs. The commonly reported ADRs associated with total ASMs were rash/urticaria (1,822, 31.8 %), dizziness (409, 7.1 %), somnolence/drowsiness (311, 5.4 %), and hepatotoxic effects (273, 4.8 %). Type B (idiosyncratic) effects (2,932; 51.1 %) were more commonly reported than Type A (related to known drug mechanisms) effects (2,613; 45.6 %). Skin and subcutaneous tissue disorders and type B effects were most commonly reported for lamotrigine and oxcarbazepine, whereas nervous system disorders and type A effects were most commonly reported for lacosamide, topiramate, and zonisamide. The pediatric group (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, National Medical Center, Seoul, South Korea.
- Department of Neurology, Konkuk University School of Medicine, Seoul, South Korea. Electronic address: drdongwkim@kuh.ac.kr.
Zitieren
APA
Kim, H. K., Jang, K. S., & Kim, D. W. (2024). Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109784
Vancouver
Kim HK, Jang KS, Kim DW. Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109784
BibTeX
@article{Kim2024,
author = {Kim, Hyun Kyung and Jang, Kyung Sik and Kim, Dong Wook},
title = {Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database},
journal = {Epilepsy & Behavior},
year = {2024},
doi = {10.1016/j.yebeh.2024.109784}
}
EUVIMED